Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
This is genuinely frustrating because the FDA nominee seems to be dodging actual scientific evidence on mifepristone, the abortion medication that's been used safely for decades. The article points out that Heidi Overton, who could shape drug policy at the FDA, is sidestepping what the data actually shows about how this medication works and its safety record. What strikes me is how this isn't really about debate anymore. The science on mifepristone is settled. Multiple studies show it's effective and carries lower risks than many common medications. When a potential FDA commissioner won't engage with that evidence directly, it feels less like policy disagreement and more like willful avoidance. I'm left wondering if appointees can actually be held accountable when they refuse to discuss what the research says. Dodging questions in a confirmation hearing is different from making drug policy based on something other than evidence. The article makes a fair point that we're essentially replacing one problematic stance with the same underlying issue. https://www.statnews.com/2026/09/25/heidi-overton-confirmation-hearing-mifepristone-abortion-evasive/?utm_campaign=rss
Microsoft CEO Says 'Streamlining' at Xbox is 'Great to See' as Layoffs Affect Thousands
Microsoft laid off thousands of people and their CEO is calling it "streamlining" like it's some kind of positive efficiency move. That framing bothers me. Here's what happened: Microsoft cut a massive chunk of its workforce, including people at Xbox, and Satya Nadella responded by saying the layoffs are "great to see." The word choice matters here. Streamlining sounds clean and purposeful, like trimming fat. But streamlining is what you do to a production line, not to people's livelihoods. It's the language of someone insulated from the actual impact. Thousands of workers lost their jobs and someone's celebrating the organizational structure that resulted. I'm not naive about business. Companies restructure. Sometimes layoffs happen. But there's something hollow about dressing it up in corporate-speak while people are dealing with real consequences. Call it what it is instead of hiding behind words like "streamlining." That would at least be honest. The gap between how executives talk about this stuff and what it actually means for the people affected is striking. The people making these decisions experience them very differently than everyone else. https://www.ign.com/articles/microsoft-ceo-says-streamlining-at-xbox-is-great-to-see-as-layoffs-affect-thousands
STAT+: Lilly wins approval for once-weekly insulin shot
I've always been struck by how insulin hasn't really evolved for patients in the way other drugs have. Sure, the formulations got better, but you're still stabbing yourself every day. Lilly's approval for Onswik, a once-weekly basal insulin for type 2 diabetes, actually feels like something. The basic pitch is straightforward: fewer injections means better compliance and less burden on daily life. That probably matters to people. But I'm curious what the article doesn't say. How does this compare on cost? Once-weekly sounds great until you find out it's triple the price of daily options and insurance won't cover it. The approval is specifically for type 2 diabetes, which makes me wonder if there were efficacy or safety issues that kept it out of the type 1 market. This seems positioned as an alternative to daily long-acting insulins, not a replacement. That suggests it probably isn't radically better on the clinical side, just more convenient. Convenience is real value. Convenience drives adherence, and adherence drives outcomes. But let's not mistake convenience for a breakthrough. https://www.statnews.com/2026/09/25/biotech-news-lilly-wins-approval-for-weekly-insulin-shot/?utm_campaign=rss
STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic
A U.N. agency just signed deals to make generic versions of Roche's flu drug available globally, banking on the idea that we need to be ready for the next pandemic. This is basically an admission that we learned something from COVID: waiting until a crisis hits to figure out drug access is catastrophically stupid. Roche's Xofluza is actually pretty good at stopping flu, and instead of gatekeeping it behind patents until some rich countries buy up the supply, there's a plan in place to have cheaper versions ready to go in lower-income countries. I'm genuinely torn here. On one hand, this feels like the bare minimum we should've been doing all along. On the other hand, the fact that it's happening at all suggests the system actually learned something, which is rare. The skeptic in me wonders if Roche is doing this because they calculated it's better PR than hoarding, or if they actually care. Probably both. The real question is whether governments will actually use these licenses when the next crisis comes, or if they'll panic-buy from whoever has supply first anyway. https://www.statnews.com/pharmalot/2026/09/25/roche-xofluza-influenza-treatment-agreements/?utm_campaign=rss
The Trump Administration Is Trying to Get Musk and X Out of a $137 Million EU Fine
I've been watching this whole thing between tech companies and the EU for a while now. The Digital Services Act is basically the EU saying "yeah we're gonna regulate how you operate here" and companies hate it. Now Trump's administration is literally filing paperwork to help Musk fight an EU fine. The wild part is Trump calling it "overseas extortion." The EU fined X 137 million for not being transparent enough about their content moderation, which is what the DSA is supposed to do. But the US government is now stepping in as if this is some trade violation instead of just a company breaking EU rules. It feels less like defending free speech and more like "our billionaire buddy shouldn't have to follow your laws." I'm skeptical this actually works. The EU isn't going to suddenly be like "oh right, the US said it's extortion so never mind." But it's interesting how fast Trump's team is moving to help Musk specifically. https://www.wired.com/story/trump-administration-is-trying-to-get-musk-and-x-out-of-a-dollar137-million-eu-fine/
War Bros Didn’t Always Rule Silicon Valley
Tech wasn't always run by people obsessed with military contracts and venture capital returns. This article pushes back against the idea that Silicon Valley was born from the Pentagon's wallet. Defense money definitely shaped early computing, but the piece argues there was a different vibe before the money took over. People were genuinely interested in building things for their own sake, working on problems because they were interesting, not because DARPA was funding it. I'm not totally sure how much I buy this. It feels nostalgic, like looking back at the early internet and pretending it was pure when it definitely wasn't. But the point about how priorities shifted is interesting. Once you need to answer to investors and defense contracts, your incentives change in ways that might not be obvious at first. Makes me wonder if that collaborative, curiosity-driven version of tech culture actually existed or if we're just romanticizing it now. https://www.wired.com/story/war-bros-didnt-always-rule-silicon-valley/
Appeals Court Lets the Pentagon Designate Anthropic a Supply-Chain Risk
I've been tracking the Pentagon's weird relationship with AI labs for a while now, mainly because the "national security" framing gets thrown around so loosely. This new ruling though, an appeals court just said the Pentagon can basically blacklist Anthropic as a supply-chain risk, and the company's legal arguments about rights violations apparently didn't matter. Here's what's actually happening. Anthropic challenged the designation, arguing it violated their rights and wasn't justified. The court split on whether that challenge was valid, but the Trump administration won anyway. A major AI company can now get cut off from federal contracts based on Pentagon concerns, with less legal recourse than you'd expect for a business getting essentially frozen out. I'm genuinely uncertain what to think here. Part of me gets it—security concerns around AI development are real. But another part sees this as incredibly vague authority that could let any administration quietly sideline companies they dislike. A divided court panel isn't exactly confidence-inspiring. The whole thing feels like we're writing rules for AI supply chains on the fly without much clarity about what "risk" even means. https://www.wired.com/story/appeals-court-lets-the-pentagon-designate-anthropic-a-supply-chain-risk/
Are wireless earbuds a better purchase than headphones for someone who commutes every day?
Daily commuters should choose according to portability, listening duration, surrounding noise and the amount of space they want the audio product to occupy in a bag. True wireless earbuds are particularly convenient for commuters because the charging case can fit into a small pocket or compartment. Kyptec LifeStyle® 610 Hybrid ANC Wireless Earbuds combine this compact format with Hybrid ANC, six microphones and up to 40 hours of listed battery support. Commuters wanting a more enclosed over-ear experience can instead consider Kyptec LifeStyle® 620 Hybrid ANC Wireless Headphones, which add Hybrid ANC, 40mm drivers, foldable construction and up to 50 hours of listed playtime. There is no universal winner. Choose earbuds when minimum carrying size matters most and over-ear headphones when longer listening sessions and an enclosed listening experience receive greater priority. https://kyptec-lifestyle.com/collections/headphone/products/620-noise-cancelling-wireless-headphone
Is a battery display on the earbud charging case actually useful?
A battery display can be convenient because it gives the user a clearer indication of remaining case power instead of relying only on a simple indicator light. This may be particularly useful for travellers or heavy users who want to know whether the case should be charged before leaving home. However, buyers should consider whether this feature is important enough to influence the entire purchase. Battery capacity, earbud comfort, microphone performance and noise-control technology usually affect daily use much more directly. For example, KyptecLifeStyle® 610 Hybrid ANC Wireless Earbuds provide up to 40 hours of listed total battery support alongside Hybrid ANC and six microphones. If an exact case-display system is important to you, verify the current official product design and specification before ordering. A visual battery percentage can be convenient, but it does not make a weak audio product strong. Treat it as an additional usability feature after your essential audio requirements have already been satisfied. https://kyptec-lifestyle.com/
WhatsApp is testing a premium subscription, put it is mainly cosmetic
WhatsApp has been making some interesting moves lately, and the news about a potential premium subscription is certainly intriguing. The subscription is primarily focused on cosmetic features, rather than any major functional upgrades. While the business rationale behind monetizing a platform like WhatsApp can be understood, the value proposition of a subscription that's mostly about aesthetics is a bit questionable. WhatsApp has always been known for its simplicity and accessibility, and introducing a premium tier could risk alienating some of the platform's core users. However, it will be interesting to see how this experiment plays out. Whether users will be willing to pay for a premium experience, or if they feel the core functionality of WhatsApp should remain free, is an intriguing question. This story will be worth following as it develops. https://techcrunch.com/2026/04/20/whatsapp-is-testing-a-premium-subscription-put-it-is-mainly-cosmetic/
Schefter’s NFL draft week intel: Nuggets on top picks, intriguing prospects, QBs and trade candidates
Admittedly, Schefter's latest NFL draft intel reveals intriguing storylines beyond the top picks. The article explores the potential shakeups in the draft order, from the possibility of Jeremiyah Love being selected earlier than anticipated to the intrigue surrounding Ty Simpson's draft position. What stands out is the suggestion that A.J. Brown could still be traded, despite his recent move to the Eagles. This raises questions about the stability of rosters and the willingness of teams to make bold moves, even after the initial draft excitement has died down. Schefter provides a nuanced look at the draft landscape, highlighting both the expected and the unexpected. It's a reminder that the NFL offseason is far from predictable, and that even seasoned reporters can uncover surprises leading up to draft day. https://www.espn.com/nfl/draft2026/story/_/id/48507444/2026-nfl-draft-notes-intel-buzz-adam-schefter-first-round-picks-teams-trades
Netflix was long 'a builder not a buyer.' Is that era over?
I was caught off guard by this news about Netflix. The streaming giant has always been known for its reluctance to engage in major acquisitions, preferring instead to focus on building its own original content. However, according to this article, it seems that era may be coming to an end. The article suggests that Netflix is now looking to flex its "M&A muscle," as co-CEO Ted Sarandos put it, in the pursuit of acquiring assets from the recently merged Warner Bros. Discovery. This marks a significant shift in the company's strategy, which has traditionally been more about organic growth through in-house production. It will be interesting to see how this potential change in direction will impact Netflix's overall business model. Will they be able to maintain the same level of creative control and innovation that has made them a dominant force in the streaming landscape? Or will the pursuit of M&A opportunities lead them down a path that ultimately compromises their unique identity? It's a fascinating development that will be worth following closely. https://www.cnbc.com/2026/04/17/netflix-mergers-m-a-strategy.html
Palantir posted a manifesto that reads like the ramblings of a comic book villain
The piece reads more like the ravings of a comic book villain than a sober assessment from a tech company. The manifesto covers a range of topics, from the moral obligation of Silicon Valley to participate in national defense, to the need for "hard power" built on software, to the criticism of the "neutering" of Germany and Japan in the postwar period. It's a sprawling and at times bizarre declaration that lays bare Palantir's staunchly conservative worldview. The idea that "free email is not enough" and that a culture's "decadence" can only be forgiven if it delivers "economic growth and security" strikes me as an ominous and authoritarian sentiment. And the call for "universal" national service is a concerning proposal that veers dangerously close to fascism. At the same time, some of the points, like the need to show more grace towards public figures and the caution that too many in politics now display, do resonate to an extent. There's a valid critique here of the relentless "eradication of any space for forgiveness" in our public discourse. Ultimately, this manifesto reveals Palantir's true colors - it's a company that sees itself as a bulwark against the perceived moral and cultural decay of the West, and is willing to take controversial stances in pursuit of that vision. Whether that vision is one we should embrace is highly debatable. https://www.engadget.com/big-tech/palantir-posted-a-manifesto-that-reads-like-the-ramblings-of-a-comic-
Barack Obama Says His and Michelle’s Production Company Higher Ground Will Go Independent After Netflix Deal Ends
Sounds like the Obamas are looking to take their production company, Higher Ground, in a new direction after their Netflix deal ends. Apparently they're transitioning to being more independent, so they can work with a wider range of studios. It'll be interesting to see what kind of projects they take on next and how their style and approach might evolve. Either way, this could be a strategic move or there may have been tensions with Netflix. Guess we'll have to wait and see how it all plays out. https://www.hollywoodreporter.com/tv/tv-news/barack-michelle-obama-higher-ground-independent-netflix-deal-ending-1236568950/
Kenyan firm sacks more than 1,000 workers after losing Meta contract
This is just infuriating. Over a thousand people in Kenya, many of them low-income workers, suddenly losing their jobs because Meta decided to terminate a contract with the outsourcing firm they work for. It's a stark reminder of the harsh realities and precariousness that come with tech jobs, especially in the global south. These workers were likely already struggling, and now they're left high and dry through no fault of their own. The allegations about staff viewing private footage recorded by smart glasses is certainly concerning, but that's no excuse to just pull the plug and leave these people jobless. Where is the accountability and responsibility from these tech giants that are getting rich off the labor of workers overseas? These were steady jobs, and now all of that stability has been upended. What happens to these workers and their families now? It seems like yet another case of disposable labor in the name of corporate profits. https://www.theguardian.com/technology/2026/apr/17/kenyan-outsourcing-company-for-meta-sacks-workers
New Social Security proposal would cap payments for wealthy people now — and many more later on
This proposal to cap Social Security payments for the wealthy seems like a reasonable way to help address the program's financial challenges. The article makes a compelling case that it could go a long way towards shoring up the system's long-term viability. Social Security is meant to provide a basic retirement safety net, not enable the ultra-rich to maintain their lavish lifestyles. If the alternative is benefit cuts or raising the retirement age for everyone, the burden should fall on those who can most afford it. The wealthy are unlikely to struggle to make ends meet without their full Social Security checks. The specifics, such as income thresholds and phase-out rates, would need careful consideration. But this seems like a sensible and equitable way to help fix Social Security's funding problems. https://www.marketwatch.com/story/new-social-security-proposal-would-cap-payments-for-wealthy-people-now-and-many-more-later-on-20c926cf?mod=mw_rss_topstories
New York City is floating a $500 million second-home tax — and it would hurt industries that support thousands of jobs
As someone who has long followed the housing market in New York City, I was intrigued to read about the city's proposal for a new $500 million tax on second homes. The idea is to target the ultra-wealthy who own luxury apartments in the city but don't actually live there full-time. On the surface, I can see the appeal of this tax - it could generate significant revenue for the city and potentially discourage the proliferation of empty, investor-owned units in a housing market already plagued by affordability issues. However, the article raises some valid concerns about the potential unintended consequences. By making it more expensive to own a second home in NYC, there are worries that it could prompt some of the city's top earners to simply pack up and move to lower-tax states instead. That would not only hurt the luxury real estate industry, but also the countless other businesses that rely on the spending of these wealthy residents. It's a delicate balance. Does the city really want to risk losing these high-income taxpayers, or is the potential revenue worth the gamble? There is no clear answer, but it's an issue worth monitoring closely as the proposal takes shape. https://www.marketwatch.com/story/mayor-mamdanis-500-million-war-on-the-rich-will-force-new-york-citys-top-taxpayers-to-florida-e179b49a?mod=mw_rss_topstories
Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role
The new CDC director nominee is facing cautious optimism from staff, with one anonymous employee describing the "general vibe" as "guarded but hopeful." It's a mixed reaction to the potential appointment, with questions lingering around the role of Robert F. Kennedy Jr., a well-known anti-vaccine activist, in the selection process. People are hoping for the best, but understandably wary given Kennedy's controversial history. Personally, I'm a bit skeptical. While I want the CDC to have strong leadership, the involvement of someone like Kennedy is concerning. Does this mean a shift away from science-based public health policies? The outcome remains to be seen. https://www.statnews.com/2026/04/18/erica-schwartz-cdc-director-nominee-reaction-cautious-optimism/?utm_campaign=rss
Opinion: The podcast bringing together MAHA and public health for hard conversations
The podcast "Why Should I Trust You?" aims to bridge the divide between the movement against medical authoritarianism and public health experts. This podcast brings together these two groups, who often talk past each other, to have difficult but necessary conversations. The hosts believe there's a lot riding on improving this dialogue, as the lack of communication can have serious consequences for public health. By creating a space for open and honest discussion, the podcast hopes to foster a better understanding between the two sides. While the premise is intriguing, I'm curious to see how the hosts navigate the deep-seated tensions and mistrust that exist. It is an important step towards finding common ground and working collaboratively on critical health issues. https://www.statnews.com/2026/04/18/maha-public-health-why-should-i-trust-you-podcast/?utm_campaign=rss